Open AccessAngiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection
Author(s) -
Gabriel Chodick,
Amir Nutman,
Naama Yiekutiel,
Varda Shalev
Publication year - 2020
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taaa069
Subject(s) - medicine , angiotensin receptor blockers , angiotensin converting enzyme , covid-19 , pharmacology , renin–angiotensin system , receptor , enzyme , angiotensin ii , angiotensin converting enzyme 2 , virology , infectious disease (medical specialty) , disease , biochemistry , blood pressure , outbreak , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom